HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reverse Engineering Can Be Least Of Fragrance IP Worries

This article was originally published in The Rose Sheet

Executive Summary

Reverse-engineering a fragrance to uncover trade secrets at least takes time and resources, unlike instances where a former employee simply delivers them to a competitor. The EU's provisional trade-secret directive will promote improved protections against such conduct but will not affect laws of contract, so confidentiality agreements will remain important tools to guard against trade-secret misappropriation.

You may also be interested in...



P&G To Disclose Fragrance Ingredients Portfolio-Wide By 2020

NGOs are trumpeting P&G's fragrance disclosure announcement as a major victory for public health and a turning point for the entire consumer products industry. The initiative, which follows a similar move from Unilever in February, will provide visibility into fragrance formulae across more than 2,000 P&G products.

IFRA’s New Prez On Fragrance Transparency, The Science/Society ‘Interface’

Four months into her presidency, the International Fragrance Association’s new head discusses key issues and priorities, including ingredient disclosure in a sector that jealously guards its trade secrets.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel